(→Assessment of the minimal distance to have fluorescence) |
(→Tripartite Split-GFP and FRB-FKBP12 dimerization systems) |
||
Line 8: | Line 8: | ||
==Tripartite Split-GFP and FRB-FKBP12 dimerization systems== | ==Tripartite Split-GFP and FRB-FKBP12 dimerization systems== | ||
− | First, we designed two biobricks to test the ''FRB*/FKBP12'' interaction and the tripartite GFP system. FRB* was fused with one subunit of the gene encoding the GFP (GFP 11) and FKBP12 was fused with another subunit (GFP10). Then, we also put the gene encoding the last subunit (GFP 1-9) in the plasmid pSB1C3 to form the tripartite GFP. | + | First, we designed two biobricks to test the ''FRB*/FKBP12'' interaction and the tripartite GFP system. FRB* was fused with one subunit of the gene encoding the GFP (GFP 11) and FKBP12 was fused with another subunit (GFP10) (cf '''Fig1'''). Then, we also put the gene encoding the last subunit (GFP 1-9) in the plasmid pSB1C3 to form the tripartite GFP (cf '''Fig2'''). |
[[Image:Paris_Saclay--design4.png|frameless|upright=2.5|center|]] | [[Image:Paris_Saclay--design4.png|frameless|upright=2.5|center|]] | ||
+ | '''Fig 1: Tripartite split-GFP and FRB*/FKBP12 functional assessment''' | ||
− | In order to test the system, we built a plasmid containing three biobricks to express the full system. Then we transformed it in ''E. coli'' to assess the system. The system would be tested by measuring GFP fluorescence level under two different conditions: a growth medium containing rapalog (rapamycin analog) and a growth medium without it. We also planed to test it in bacteria containing just two parts (FRB-GFP11 and FKBP12-GFP10) instead of three (so without GFP1-9). | + | |
+ | In order to test the system, we built a plasmid containing three biobricks to express the full system (cf '''Fig2'''). Then we transformed it in ''E. coli'' to assess the system. The system would be tested by measuring GFP fluorescence level under two different conditions (cf '''Fig1'''): a growth medium containing rapalog (rapamycin analog) and a growth medium without it. We also planed to test it in bacteria containing just two parts (FRB-GFP11 and FKBP12-GFP10) instead of three (so without GFP1-9). | ||
[[Image:Paris_Saclay--design5.png|frameless|upright=2.5|center|]] | [[Image:Paris_Saclay--design5.png|frameless|upright=2.5|center|]] | ||
+ | '''Fig 2: Biobrick design containing all the parts to characterize tripartite split-GFP and FRB*/FKBP12''' | ||
This construction would give give us our first results and validate the functionality of the tripartite GFP and check the dimerization of FRB* and FKBP12. | This construction would give give us our first results and validate the functionality of the tripartite GFP and check the dimerization of FRB* and FKBP12. |
Revision as of 14:29, 17 October 2016